RTÉ's Economics and Public Affairs Editor David Murphy examines some of the key issues around how US President Donald Trump's ...

U.S. President Donald Trump showed little signs of backing down on his plans to tariff the world Thursday — even as members of his administration continued to claim the duties will lead to the ...

MICHAEL BECKLEY is Associate Professor of Political Science at Tufts University, a Nonresident Senior Fellow at the American ...

The Dow dropped sharply, falling 533 points, or 1.3%, to 39,137. The blue-chip index was dragged down almost singlehandedly ...

Immigration lawyers provide advice on US travel, as border security officials conduct "enhanced vetting" of travellers with ...

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

Sun Pharma declined 0.93 per cent to Rs 1,689.35. About10 per cent of the Sun Pharma's US specialty revenues is formulated in ...

Passing such a law would give consumers "more access to pharmaceutical care" at "more affordable prices," the attorneys ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

An investigation into the national security implications of pharma imports has been underway for two weeks, the Trump ...